ATE71524T1 - Waessriges natriumcromoglycat enthaltende mittel. - Google Patents

Waessriges natriumcromoglycat enthaltende mittel.

Info

Publication number
ATE71524T1
ATE71524T1 AT85308367T AT85308367T ATE71524T1 AT E71524 T1 ATE71524 T1 AT E71524T1 AT 85308367 T AT85308367 T AT 85308367T AT 85308367 T AT85308367 T AT 85308367T AT E71524 T1 ATE71524 T1 AT E71524T1
Authority
AT
Austria
Prior art keywords
aqueous sodium
containing compositions
cromoglycat
formulation
sodium cromoglycat
Prior art date
Application number
AT85308367T
Other languages
English (en)
Inventor
Emmett Clemente
Henry Pfeifer
Lee Vincent Hon-Kin
Joseph Robinson
Original Assignee
Fisons Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24706028&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE71524(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fisons Plc filed Critical Fisons Plc
Application granted granted Critical
Publication of ATE71524T1 publication Critical patent/ATE71524T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Detergent Compositions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Steroid Compounds (AREA)
AT85308367T 1984-11-23 1985-11-18 Waessriges natriumcromoglycat enthaltende mittel. ATE71524T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67428284A 1984-11-23 1984-11-23
EP85308367A EP0183457B1 (de) 1984-11-23 1985-11-18 Wässriges Natriumcromoglycat enthaltende Mittel

Publications (1)

Publication Number Publication Date
ATE71524T1 true ATE71524T1 (de) 1992-02-15

Family

ID=24706028

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85308367T ATE71524T1 (de) 1984-11-23 1985-11-18 Waessriges natriumcromoglycat enthaltende mittel.

Country Status (18)

Country Link
EP (1) EP0183457B1 (de)
JP (1) JPH0639379B2 (de)
AT (1) ATE71524T1 (de)
AU (2) AU4999785A (de)
BE (1) BE903701A (de)
CA (1) CA1267848A (de)
CH (1) CH666816A5 (de)
DE (1) DE3585211D1 (de)
DK (1) DK541285A (de)
FR (1) FR2573652B1 (de)
GB (1) GB2167300B (de)
GR (1) GR852791B (de)
IE (1) IE59195B1 (de)
IL (1) IL77086A0 (de)
LU (1) LU86172A1 (de)
NZ (1) NZ214295A (de)
PT (1) PT81538A (de)
ZA (1) ZA858914B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1317226C (en) * 1987-05-04 1993-05-04 Phillip E. Pennell Viscoelastic fluid for ophthalmic surgery and method of using same
ES2012532A6 (es) * 1988-07-15 1990-04-01 Cusi Lab Un procedimiento para la preparacion de una solucion acuosa de b-metil-4-(2' -tienilcarbonil)fenilacetato de lisina para aplicacion topica oftalmica.
EP0444778A1 (de) * 1990-02-14 1991-09-04 Alcon Laboratories, Inc. Verwendung von Alkylsacchariden zur Förderung der Penetration von Arzneistoffen
DE19539532C2 (de) * 1995-10-24 1999-02-25 Mann Gerhard Chem Pharm Fab Ophthalmisches Cromoglicat-Gelpräparat
DE20022450U1 (de) * 1999-01-19 2002-01-17 Mann Gerhard Chem Pharm Fab Künstliche Tränenflüssigkeit in Gelform
JP5364658B2 (ja) * 2000-07-21 2013-12-11 ロート製薬株式会社 点眼剤
JP2002097129A (ja) * 2000-07-21 2002-04-02 Rohto Pharmaceut Co Ltd 点眼剤
WO2005003111A1 (ja) * 2003-07-04 2005-01-13 Astellas Pharma Inc. ウィルス性結膜炎の予防または治療剤
FR2860718B1 (fr) * 2003-10-09 2006-02-24 Jean Pascal Conduzorgues Nouvelle formulation et ses applications dans le domaines cosmetiques ou pharmaceutiques
EP2248517B1 (de) * 2009-05-08 2014-03-26 PARI Pharma GmbH Konzentrierte mastzellenstabilisierende pharmazeutische Formulierungen
JP2013231185A (ja) * 2013-06-12 2013-11-14 Pfizer Products Inc ヒドロキシプロピルメチルセルロース硬カプセルおよび製造方法
SI3104853T1 (sl) 2014-02-10 2020-03-31 Respivant Sciences Gmbh Zdravljenje s stabilizatorji mastocitov za sistemske motnje
EP3725311A1 (de) 2014-02-10 2020-10-21 Respivant Sciences GmbH Verfahren zur behandlung von lungenerkrankungen mit mastzellstabilisatoren
WO2017027402A1 (en) 2015-08-07 2017-02-16 Patara Pharma, LLC Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders
US10238625B2 (en) 2015-08-07 2019-03-26 Respivant Sciences Gmbh Methods for the treatment of mast cell related disorders with mast cell stabilizers
CN110139646A (zh) 2016-08-31 2019-08-16 瑞思皮万特科学有限责任公司 用于治疗由特发性肺纤维化引起的慢性咳嗽的色甘酸组合物
AU2017339366A1 (en) 2016-10-07 2019-04-11 Respivant Sciences Gmbh Cromolyn compositions for treatment of pulmonary fibrosis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1473318A (en) * 1973-05-25 1977-05-11 Fisons Ltd Solution of 1,3-bis-2-carboxychromon-5-yloxy-propan-2-ol or salts thereof
US4053628A (en) * 1971-05-12 1977-10-11 Fisons Limited Composition
FR2230358A2 (en) * 1973-05-25 1974-12-20 Fisons Ltd Cromoglycate contg. solns. - contg. a second therapeutically active cpd. e.g. an antihistamine
IL48360A (en) * 1974-11-09 1978-12-17 Fisons Ltd Pharmaceutical compositions for the treatment of aphthous stomatitis comprising 1,3-bis-(2-carboxychromon-5-yloxy)-2-carboxychromon-5-yloxy)-2-hydroxypropane
US4268519A (en) * 1979-06-05 1981-05-19 Fisons Limited Method of treating otitis media
JPS5756448A (en) * 1980-09-22 1982-04-05 Mitsui Toatsu Chem Inc Preparation of aromatic isocyanate

Also Published As

Publication number Publication date
IE852942L (en) 1986-05-23
AU4999785A (en) 1986-05-29
EP0183457B1 (de) 1992-01-15
FR2573652A1 (fr) 1986-05-30
AU4431189A (en) 1990-02-22
GB2167300A (en) 1986-05-29
PT81538A (en) 1985-12-01
GB8528190D0 (en) 1985-12-18
JPS61143318A (ja) 1986-07-01
EP0183457A3 (en) 1987-04-15
NZ214295A (en) 1988-07-28
GR852791B (de) 1986-03-21
CH666816A5 (fr) 1988-08-31
DK541285A (da) 1986-05-24
IL77086A0 (en) 1986-04-29
LU86172A1 (fr) 1986-03-24
BE903701A (fr) 1986-05-22
DK541285D0 (da) 1985-11-22
FR2573652B1 (fr) 1988-09-02
GB2167300B (en) 1988-11-23
IE59195B1 (en) 1994-01-26
ZA858914B (en) 1987-07-29
EP0183457A2 (de) 1986-06-04
JPH0639379B2 (ja) 1994-05-25
DE3585211D1 (de) 1992-02-27
CA1267848A (en) 1990-04-17

Similar Documents

Publication Publication Date Title
ATE71524T1 (de) Waessriges natriumcromoglycat enthaltende mittel.
PT89835A (pt) Processo para a preparacao de uma formulacao de relaxina humana
DK486282A (da) Fremgangsmaade til fremstilling af 5- eller 6-hydroxy-2-benzothiazolsulfonamider
DK159889A (da) Hudplejepraeparat, dets fremstilling og anvendelse
DK159789A (da) Medikeret hudplejepraeparat, dets fremstilling og anvendelse
PT77898B (en) Process for the preparation of substituted 4-amino-methylenochromanes and 4-aminomethylenecromenes acting on the blood circulation and application thereof in the preparation of pharmaceutical compositions acting on the blood circulation
ATE78691T1 (de) Sucralfat-suspension zur verwendung in der behandlung von geschwueren.
ATE80281T1 (de) Haarstabilisator.
EP0363469A4 (en) Lacrimal secretion stimulant (lss)
IL58299A (en) Fluorine-containing 1,4-dihydropyridine derivatives,their production and their medicinal use
ES2092868T3 (es) Utilizacion de derivados de la 4-tiorresorcina en unas composiciones cosmeticas o dermofarmaceuticas de accion despigmentante.
YU46561B (sh) Postupak za stabilizaciju vodenog rastvora ranitidina
SE8801710L (sv) New ophtalmological composition of matter
AR241243A1 (es) Nuevos derivados de 1-fenil-1-oximino-haloalquilo procedimiento para su preparacion y composiciones que los contienen.
PT93915A (pt) Processo para a preparacao de novos derivados de 4-fenil-metil-1h-indol e de composicoes farmaceuticas que os contem
IT1254712B (it) Uso dell'acido ialuronico lubrificante di protesi oculari.
ES2096559T3 (es) Interferon gamma humano, procedimiento para la preparacion de dicho interferon gamma humano, y su uso.
ES2038799T3 (es) Derivados de 3-ciano-4-fenil-pirrol.
ES2085833B1 (es) Derivados de carboximetilidencicloheptimidazol y metodo para prepararlos.
ES540308A0 (es) Un procedimiento de producir un agente promotor de la erec- cion y de la fertilidad

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee
RZN Patent revoked